Please Wait...

ClinPlan Chooses BioClinica Optimizer for Clinical Supply Chain Simulation

July 18, 2012

July 18, 2012.  NEWTOWN, PA – BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions has partnered with ClinPlan, LLC, a niche consulting and staffing provider to the biopharmaceutical industry, to deliver clinical supply simulation services in conjunction with BioClinica Optimizer, the only clinical trial supply forecasting tool that fine tunes and validates the mathematical optimization process using clinical trial simulation to more accurately eliminate unnecessary overage, minimize drug waste and reduce trial costs.

"We are honored to have been selected as ClinPlan's tool of choice for providing clinical supply chain simulation services to their clients," said Peter Benton, President of BioClinica's eClinical Solutions. "We look forward to growing our relationship and working closely with them in the years to come."

ClinPlan initially contacted BioClinica to hear more about offerings for clinical supply chain simulation. After learning more about the integration between BioClinica Optimizer and various Interactive Response Technology systems (IRT), ClinPlan entered into an agreement with BioClinica in April 2012 to partner with BioClinica for its current and future engagements. The companies have already begun working together on mutual customers.

"We could not be more thrilled to partner with BioClinica to deliver the best and most efficient solutions to our clients," said Spencer Comtois, Ph.D., Principal Consultant and CEO of ClinPlan. "BioClinica's services and best-in-class technology answer our customers' needs to maximize efficiencies across the clinical supply chain."

Peter Benton, President of BioClinica's eClinical Solutions stated, "BioClinica is always looking for opportunities to partner with the best and brightest in the industry. ClinPlan's services bring a fresh alternative to both our existing clients and potential customers. We are happy to pair our best-of-breed supply chain solutions with ClinPlan's experience and knowledge base to understand and meet client expectations."

By working collaboratively, both companies expect to develop new ways to integrate Optimizer into more clinical trials, eliminating unnecessary waste and minimizing the challenges that inevitably arise with managing the complexities of clinical supply chains.

Follow ClinPlan on Twitter at http://twitter.com/clinplanman.

About ClinPlan, LLC
ClinPlan is a niche consulting and staffing provider to the biopharmaceutical industry with a specific focus on the clinical supply chain. This unique organization services their customers by implementing robust processes and driving efficiencies when manufacturing, packaging and distributing investigational products for human clinical trials. With an extensive suite of time-tested processes and tools that can be tailored to a client's specific requirements, ClinPlan can help clients rapidly achieve compliance, realize efficiencies and accomplish significant cost savings. In addition, they have a team of passionate and seasoned professionals that are adept at processes implementation and management of clinical supply chain projects. By taking the approach of looking at the supply chain holistically, ClinPlan makes sure the solutions they provide are integrated from the demand gathering stage through to destruction of unused clinical supplies. ClinPlan operates a mobile business working at client sites or remotely at their corporate offices in Flemington, New Jersey. For more information, please visit www.ClinPlan.com.

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices